Over-the-counter drug · UNAPPROVED DRUG OTHER
Stix Maximum Strength Urinary Pain Relief NDC 80584-113
phenazopyridine hydrochloride · Phenazopyridine hydrochloride 99.5 mg/1 · Tablet · Oral · Get Stix Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80584-113-24 | 80584011324 | 1 BLISTER PACK in 1 CARTON (80584-113-24) / 24 TABLET in 1 BLISTER PACKMarketed from Sep 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Stix Maximum Strength Urinary Pain Relief
- Generic name (nonproprietary)
- phenazopyridine hydrochloride
- Active ingredients
- Phenazopyridine hydrochloride — 99.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Get Stix Inc.
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 80584-113_5b2fff04-b2e5-43a4-90f2-b31997a317efSPL ID 5b2fff04-b2e5-43a4-90f2-b31997a317efSPL set ID faf6b5c0-6ff5-482c-9ad5-a7bef92afd56RxCUI 1094147UNII 0EWG668W17UPC 0860002060460
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480584011324followed by a unit qualifier and the quantityPackage 80584-0113-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
Excerpt only. Read the full label for complete information.